StoryHardware
Roche launches Axelios 1 sequencing platform with same-day whole-genome capability
Roche launched Axelios 1, a next-generation sequencing platform powered by proprietary sequencing-by-expansion (SBX) technology. The platform delivers same-day whole-genome sequencing using CMOS nanopore sensors and is for research use only, with clinical FDA submission planned.
- SBX technology expands DNA/RNA into larger polymers (Xpandomers) for improved detection
- Delivers whole-genome results and variant analysis the same day from sample to output
- First serious sequencing challenger to Illumina from a major pharmaceutical company
- Priced at $750,000 USD and supported by partnerships with 10x Genomics and research institutions